Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Wockhardt
Welcome,
Profile
Billing
Logout
10 Products
6 Diseases
10 Products
2 Trials
256 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
nafithromycin
(WCK 4873) / Wockhardt
Emrok O
(alalevonadifloxacin) / Wockhardt
cefepime/zidebactam IV
(WCK 5222) / Wockhardt
Wosulin R
(recombinant human insulin biosimilar) / Wockhardt
Emrok
(levonadifloxacin) / Wockhardt
cefepime/tazobactam
(WCK 4282) / Wockhardt
Glaritus
(insulin glargine biosimilar) / Wockhardt
Wosulin 30/70
(recombinant human insulin biosimilar 30% + isophane insulin biosimilar 70%) / Wockhardt
Wosulin N
(isophane insulin biosimilar) / Wockhardt
ertapenem/zidebactam
(WCK 6777) / Wockhardt
